Nearly one in 10 patients with end-stage kidney failure undergoes toe, foot, or leg amputation in their last year of life. During this time, these patients have prolonged stays in healthcare settings and limited access to hospice services.
Experimental gene therapy cassettes for Duchenne muscular dystrophy have been modified to deliver better performance. The cassettes, which carry the therapy into muscle cells, contain newer versions of a miniaturized treatment gene.
Studies of human monoclonal antibodies isolated from survivors of coronavirus-induced severe acute respiratory syndrome (SARS) or Middle-East respiratory syndrome (MERS) are unveiling surprising immune defense tactics against fatal viruses.